Koga S, Sekiya H, Kondru N, Ross OA, Dickson DW. Neuropathology and molecular diagnosis of Synucleinopathies. Mol Neurodegener [Internet]. 2021 Dec 1 [cited 2022 Dec 22];16(1):83.https://doi.org/10.1186/s13024-021-00501-z.
Ubhi K, Low P, Masliah E. Multiple system atrophy: a clinical and neuropathological perspective. Trends Neurosci [Internet]. 2011;34(11):581–90.
Article CAS PubMed Google Scholar
Wüllner U, Borghammer P, Choe C un, Csoti I, Falkenburger B, Gasser T et al. The heterogeneity of Parkinson’s disease. J Neural Transm [Internet]. 2023;130(6):827–38.
Fung TC, Olson CA, Hsiao EY. Interactions between the microbiota, immune and nervous systems in health and disease. Nat Neurosci. 2017;20(2):145–55.
Article CAS PubMed PubMed Central Google Scholar
Jurcau A, Andronie-Cioara FL, Nistor-Cseppento DC, Pascalau N, Rus M, Vasca E, et al. The involvement of Neuroinflammation in the Onset and Progression of Parkinson’s Disease. Int J Mol Sci. 2023;24:19.
Peelaerts W, Mercado G, George S, Villumsen M, Kasen A, Aguileta M et al. Urinary tract infections trigger synucleinopathy via the innate immune response. Acta Neuropathol [Internet]. 2023 [cited 2023 May 3];145(5).
Joers V, Tansey MG, Mulas G, Carta AR. Microglial phenotypes in Parkinson’s disease and animal models of the disease. Prog Neurobiol [Internet]. 2017;155(2015):57–75.
Article CAS PubMed Google Scholar
Long-Smith CM, Sullivan AM, Nolan YM. The influence of microglia on the pathogenesis of Parkinson’s disease. Prog Neurobiol. 2009;89(3):277–87.
Article CAS PubMed Google Scholar
Sanchez-Guajardo V, Barnum CJ, Tansey MG, Romero-Ramos M. Neuroimmunological processes in Parkinson’s Disease and their relation to α-Synuclein: Microglia as the referee between neuronal processes and peripheral immunity. ASN Neuro [Internet]. 2013;5(2):AN20120066.
Harms AS, Yang YT, Tansey MG. Central and peripheral innate and adaptive immunity in Parkinson’s disease. Sci Transl Med [Internet]. 2023 Nov 8 [cited 2023 Nov 23];15(721):eadk3225.
Capelle CM, Ciré S, Hedin F, Hansen M, Pavelka L, Grzyb K, et al. Early-to-mid stage idiopathic Parkinson’s disease shows enhanced cytotoxicity and differentiation in CD8 T-cells in females. Nat Commun [Internet]. 2023;14(1):7461. [cited 2023 Nov 23];.
Article CAS PubMed Google Scholar
Lauritsen J, Romero-Ramos M. The systemic immune response in Parkinson’s disease: focus on the peripheral immune component. Trends Neurosci. 2023;46(10):863–78.
Article CAS PubMed Google Scholar
Woulfe J, Hoogendoorn H, Tarnopolsky M, Muñoz DG. Monoclonal antibodies against Epstein-Barr virus cross-react with α-synuclein in human brain. Neurology. 2000;55(9):1398–401.
Article CAS PubMed Google Scholar
Woulfe JM, Gray MT, Gray DA, Munoz DG, Middeldorp JM. Hypothesis: a role for EBV-induced molecular mimicry in Parkinson’s disease. Parkinsonism Relat Disord [Internet]. 2014;20(7):685–94.
Sulzer D, Alcalay RN, Garretti F, Cote L, Kanter E, Agin-Liebes J, et al. T cells from patients with Parkinson’s disease recognize α-synuclein peptides. Nat [Internet]. 2017;546(7660):656–61.
de Fàbregues O, Sellés M, Ramos-Vicente D, Roch G, Vila M, Bové J. Relevance of tissue-resident memory CD8 T cells in the onset of Parkinson’s disease and examination of its possible etiologies: infectious or autoimmune? Neurobiol Dis. 2023;187(September).
Gate D, Tapp E, Leventhal O, Shahid M, Nonninger TJ, Yang AC, et al. CD4 + T cells contribute to Neurodegeneration in Lewy Body Dementia. Sci (1979). 2021;374:868–74.
Shadrin AA, Mucha S, Ellinghaus D, Makarious MB, Blauwendraat C, Sreelatha AAK, et al. Shared Genetics of multiple system atrophy and inflammatory bowel disease. Mov Disord. 2021;36(2):449–59.
Article CAS PubMed Google Scholar
Conway KS, Camelo-Piragua S, Fisher-Hubbard A, Perry WR, Shakkottai VG, Venneti S. Multiple system atrophy pathology is associated with primary Sjögren’s syndrome. JCI Insight. 2020;5(15):1–13.
Rydbirk R, Østergaard O, Folke J, Hempel C, DellaValle B, Andresen TL, et al. Brain proteome profiling implicates the complement and coagulation cascade in multiple system atrophy brain pathology. Cell Mol Life Sci [Internet]. 2022;79(6):336. https://doi.org/10.1007/s00018-022-04378-z.
Article CAS PubMed Google Scholar
Ge Q, Gu X, Yu W, Zhang G, Liang W, Li M et al. Antinuclear antibodies in healthy population: Positive association with abnormal tissue metabolism, inflammation and immune dysfunction. Int Immunopharmacol [Internet]. 2022;113(PA):109292.
Irure-Ventura J, López-Hoyos M. The past, Present, and future in antinuclear antibodies (ANA). Diagnostics. 2022;12(3).
Agmon-Levin N, Damoiseaux J, Kallenberg C, Sack U, Witte T, Herold M et al. International recommendations for the assessment of autoantibodies to cellular antigens referred to as anti-nuclear antibodies. Ann Rheum Dis [Internet]. 2014 Jan 1 [cited 2023 Nov 24];73(1):17–23.
Dei Zotti F, Moriconi C, Qiu A, Miller A, Hudson KE. Distinct CD4 + T cell signature in ANA-positive young adult patients. Front Immunol. 2022;13(October):1–11.
Lin L, Hang H, Zhang J, Lu J, Chen D, Shi J. Clinical significance of anti-SSA/Ro antibody in Neuromyelitis Optica spectrum disorders. Mult Scler Relat Disord [Internet]. 2022;58(2022):103494.
Article CAS PubMed Google Scholar
Dalitis S, Filippidou N, Krashias G, Christodoulou C, Pantzaris M, Lambrianides A. The possible role of an autoimmune mechanism in the etiopathogenesis of Parkinson’s disease. J Clin Neurosci [Internet]. 2018;54(2018):63–8.
Article CAS PubMed Google Scholar
Marchese M, Cowan D, Head E, Ma D, Karimi K, Ashthorpe V, et al. Autoimmune manifestations in the 3xtg-ad model of alzheimer’s disease. J Alzheimer’s Disease. 2014;39(1):191–210.
Postuma RB, Berg D, Stern M, Poewe W, Olanow CW, Oertel W, et al. MDS clinical diagnostic criteria for Parkinson’s disease. Mov Disord. 2015;30(12):1591–601.
McKeith IG, Boeve BF, Dickson DW, Halliday G, Taylor JP, Weintraub D, et al. Diagnosis and management of dementia with Lewy bodies. Neurology. 2017;89(1):88–100.
Article PubMed PubMed Central Google Scholar
Gilman S, Wenning FG, Low P, Brooks FD, Mathias FC, Trojanowski FJ et al. Second consensus statement on the diagnosis of multiple system atrophy Background: A consensus conference on multiple system atrophy (MSA) in 1998 established. Neurology. 2008;71:670–6.
Damoiseaux J, Andrade LEC, Carballo OG, Conrad K, Francescantonio PLC, Fritzler MJ, et al. Clinical relevance of HEp-2 indirect immunofluorescent patterns: the International Consensus on ANA patterns (ICAP) perspective. Ann Rheum Dis. 2019;78(7):879–89.
Article CAS PubMed Google Scholar
Conrad K, Röber N, Andrade LEC, Mahler M. The clinical relevance of Anti-DFS70 autoantibodies. Clin Rev Allergy Immunol. 2017;52(2):202–16.
Article CAS PubMed Google Scholar
Folke J, Rydbirk R, Løkkegaard A, Salvesen L, Hejl AM, Starhof C et al. Distinct autoimmune anti-α-synuclein antibody patterns in multiple system atrophy and parkinson’s disease. Front Immunol. 2019;10(SEP).
Benkler M, Agmon-Levin N, Hassin-Baer S, Cohen OS, Ortega-Hernandez OD, Levy A, et al. Immunology, autoimmunity, and autoantibodies in parkinson’s disease. Clin Rev Allergy Immunol [Internet]. 2012;42(2):164–71. Apr 14 [cited 2023 Nov 24];.
Article CAS PubMed Google Scholar
Garretti F, Agalliu D, Arlehamn CSL, Sette A, Sulzer D. Autoimmmunity in parkinson’s disease: the role of α:-synuclein-specific T cells. Front Immunol. 2019;10(FEB):1–12.
Bonam SR, Muller S. Parkinson’s disease is an autoimmune disease: a reappraisal. Autoimmun Rev [Internet]. 2020;19(12):102684.
Article CAS PubMed Google Scholar
Prüss H. Autoantibodies in neurological disease. Nat Rev Immunol. 2021;21(12):798–813.
Article PubMed PubMed Central Google Scholar
Selmi C, Barin JG, Rose NR. Current trends in autoimmunity and the nervous system. J Autoimmun [Internet]. 2016;75(2016):20–9.
Kocurova G, Ricny J, Ovsepian SV. Autoantibodies targeting neuronal proteins as biomarkers for neurodegenerative diseases. Theranostics. 2022;12(7):3045–56.
Article CAS PubMed PubMed Central Google Scholar
Folke J, Rydbirk R, Løkkegaard A, Hejl AM, Winge K, Starhof C, et al. Cerebrospinal fluid and plasma distribution of anti-α-synuclein IgMs and IgGs in multiple system atrophy and Parkinson’s disease. Parkinsonism Relat Disord. 2021;87(April):98–104.
Article CAS PubMed Google Scholar
Agmon-Levin N, Damoiseaux J, Kallenberg C, Sack U, Witte T, Herold M et al. International recommendations for the assessment of autoantibodies to cellular antigens referred to as anti-nuclear antibodies. Ann Rheum Dis [Internet]. 2014 Jan 1 [cited 2024 Apr 26];73(1):17–23.
Pashnina IA, Krivolapova IM, Fedotkina TV, Ryabkova VA, Chereshneva MV, Churilov LP, et al. Antinuclear autoantibodies in health: autoimmunity is not a synonym of autoimmune disease. Antibodies. 2021;10(1):1–26.
Folke J, Rydbirk R, Løkkegaard A, Salvesen L, Hejl AM, Starhof C, et al. Distinct autoimmune Anti-α-Synuclein antibody patterns in multiple system atrophy and Parkinson’s Disease. Front Immunol [Internet]. 2019;10:2253. [cited 2024 Jan 22];.
留言 (0)